BTG Pactual Global Asset Management’s Emergent Biosolutions EBS Stock Holding History

BTG Pactual Global Asset Management’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-15,980	Closed	-$455K	–	53
2015 Q3	$455K	Hold	15,980	–	–	0.04%	150
2015 Q2	$527K	Buy	+15,980	New	+$495K	0.03%	145
2014 Q4	–	Sell	-15,365	Closed	-$327K	–	183
2014 Q3	$327K	Hold	15,365	–	–	0.04%	159
2014 Q2	$345K	Buy	+15,365	New	+$358K	0.05%	189

Other funds holding EBS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

BTG Pactual Global Asset Management's EBS Position: Q4 2015 in Review

BTG Pactual Global Asset Management sold out of Emergent Biosolutions (EBS) in Q4 2015, closing a stake of 15,980 shares — an estimated $455K sold.

BTG Pactual Global Asset Management first reported a position in EBS in Q2 2014 and held it in 4 quarters. The position peaked at $527K in Q2 2015. 206 funds tracked by Wall St. Rank hold EBS as of Q4 2015.

BTG Pactual Global Asset Management reported no remaining Emergent Biosolutions position as of Q4 2015 after selling out during the quarter.
BTG Pactual Global Asset Management sold 15,980 Emergent Biosolutions shares in Q4 2015, an estimated $455K.
BTG Pactual Global Asset Management first reported a position in Emergent Biosolutions in Q2 2014 and held it in 4 quarters.
BTG Pactual Global Asset Management's Emergent Biosolutions position peaked at $527K in Q2 2015.
206 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2015.

Based on BTG Pactual Global Asset Management's 13F filing for Q4 2015, filed 12 Feb 2016.